Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Change in Accured Expenses of $2.4 million in Q4 2025, down 48.59% quarter-over-quarter from $4.7 million in Q3 2025, and down 35.5% on a YoY basis from $3.8 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $2.4 million for Q4 2025.

  • In Q4 2025, Change in Accured Expenses fell 35.5% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $9.0 million (up 317.72% YoY), while the FY2025 annual figure was $7.0 million, up 143.07% from the prior year.
  • Change in Accured Expenses was $2.4 million for Q4 2025 at Prestige Consumer Healthcare, down from $4.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $18.4 million in Q2 2021 to a low of -$23.1 million in Q1 2021.
  • Historically, Change in Accured Expenses has averaged -$283250.0 across 5 years, with a median of $830500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 379.42% in 2023, then plunged 453.98% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$9.5 million in 2021, then soared by 84.84% to -$1.4 million in 2022, then soared by 379.42% to $4.0 million in 2023, then fell by 6.37% to $3.8 million in 2024, then tumbled by 35.5% to $2.4 million in 2025.
  • The last three Change in Accured Expenses figures came in at $2.4 million (Q4 2025), $4.7 million (Q3 2025), and -$813000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -144.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -234.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -12.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -14.30 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 4.89 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 23.00 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 10.02 Mn
10 Prestige Consumer Healthcare 2.39 Bn 2.33 Bn 157.37 Mn 2.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.44 Mn
Dec 31, 2025 2.44 Mn
Sep 30, 2025 4.74 Mn
Sep 30, 2025 4.74 Mn
Jun 30, 2025 -813,000.00
Jun 30, 2025 -813,000.00
Mar 31, 2025 2.63 Mn
Mar 31, 2025 2.63 Mn
Dec 31, 2024 3.78 Mn
Dec 31, 2024 3.78 Mn
Sep 30, 2024 2.65 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 -2.06 Mn
Jun 30, 2024 -2.06 Mn
Mar 31, 2024 -8.49 Mn
Mar 31, 2024 -8.49 Mn
Dec 31, 2023 4.03 Mn
Dec 31, 2023 4.03 Mn
Sep 30, 2023 -3.25 Mn
Sep 30, 2023 -3.25 Mn